2025年1-11月，化学原料和化学制品制造业企业数（以下数据涉及的企业，均为规模以上工业企业，从 2011年起，规模以上工业企业起点标准由原来的年主营业务收入500万元提高到年主营业务收入2000万 元）为27102个，和上年同期相比，增加了815个，同比增长3.1%，占工业总企业的比重为5.15%。 2016-2025年1-11月化学原料和化学制品制造业企业数统计图 数据来源：国家统计局，智研咨询整理 上市公司：海南海药（000566），东北制药（000597），亚太实业（000691），通化金马（000766）， 北大医药（000788），力生制药（002393），海普瑞（002399），科伦药业（002422），杭氧股份 （002430），长江健康（002435），誉衡药业（002437），华软科技（002453） 相关报告：智研咨询发布的《2026-2032年中国有机化学原料制造行业市场分析研究及产业前景研判报 告》 知前沿，问智研。智研咨询是中国一流产业咨询机构，十数年持续深耕产业研究领域，提供深度产业研 究报告、商业计划书、可行性研究报告及定制服务等一站式产业咨询服务。专业的角度、品质化的服 务 ...

Group 1 - Two A-shares are set for equity registration today, with both companies planning to distribute dividends [1] - The dividend registration date for the two stocks is January 16, with Vision Intelligence and Aladdin offering the highest dividends of 3.00 yuan and 0.70 yuan per 10 shares, respectively [1] - Additionally, three other stocks have announced dividend distribution plans, with Life Pharmaceutical and Tianshan Aluminum proposing the highest dividends of 3.0 yuan and 1.0 yuan per 10 shares, respectively [1]

Core Viewpoint - Several companies are expected to turn losses into profits in 2025, driven by improved market conditions and strategic initiatives. Group 1: Companies Expected to Turn Profits - Dongli New Science forecasts a net profit of 2.752 billion to 2.852 billion yuan for 2025, recovering from a loss of 843 million to 643 million yuan in the previous year [2] - Tianji Co. anticipates a net profit of 70 million to 105 million yuan in 2025, compared to a loss of 1.361 billion yuan in the previous year [2] - Haowu Co. expects a net profit of 42 million to 54 million yuan for 2025, recovering from a loss of 20.057 million yuan [4] - Xue Rong Bio predicts a net profit of 29 million to 40 million yuan in 2025, recovering from a loss of 617 million yuan [4] - Beisi Mei forecasts a net profit of 23.68 million to 34.06 million yuan for 2025, compared to a loss of 32.8646 million yuan [5] Group 2: Significant Corporate Changes - Tian Sheng New Materials plans to change its controlling shareholder and actual controller, with shares being transferred at 6.39 yuan per share [6][7] - Zhizhi New Materials and *ST Chengchang have completed their verification work and will resume trading on January 16, 2026 [8] Group 3: Performance Forecasts - SAIC Group expects a net profit of 9 billion to 11 billion yuan for 2025, an increase of 7.3 billion to 9.3 billion yuan from the previous year, representing a growth of 438% to 558% [10] - Sanmei Co. anticipates a net profit of 1.9903846 billion to 2.1496154 billion yuan for 2025, an increase of 1.2118480 billion to 1.3710788 billion yuan, reflecting a growth of 155.66% to 176.11% [10] - Futek Technology expects a net profit of 210 million to 250 million yuan for 2025, a growth of 121.98% to 164.26% [11] - Zhenyu Technology forecasts a net profit of 500 million to 550 million yuan for 2025, an increase of 96.89% to 116.58% [11] - Jinwo Co. expects a net profit of 46 million to 52 million yuan for 2025, a growth of 76% to 98.96% [12]

证券日报网讯 1月15日，力生制药发布公告称，公司将于2026年2月2日召开2026年第一次临时股东会。 （文章来源：证券日报） ...

证券日报网讯 1月15日，力生制药发布公告称，公司于2026年1月15日召开第八届董事会第三次会议， 审议通过了《2025年前三季度利润分配的预案》。 （文章来源：证券日报） ...

Group 1 - Siyuan Electric reported a total operating revenue of 21.205 billion yuan for 2025, a year-on-year increase of 37.18%, with a net profit attributable to shareholders of 3.163 billion yuan, up 54.35% year-on-year [1] - VisiOn expects a negative net profit for 2025, indicating a loss in operating performance [2] - Chongqing Steel anticipates a net loss of 2.5 billion to 2.8 billion yuan for 2025, which is an improvement from a net loss of 3.196 billion yuan in the previous year [3] - Lianfa Co. forecasts a net profit of 280 million to 320 million yuan for 2025, representing a year-on-year growth of 38.92% to 58.77% [4] Group 2 - CICC announced that the audit work related to the absorption merger with Dongxing Securities and Xinda Securities has not yet been completed [5] - Dalong Real Estate's subsidiary won a project bid worth 763 million yuan [6] - Zhongchuang Zhiling plans to issue convertible bonds to raise no more than 4.35 billion yuan for various projects [7] - Jintong Co. intends to acquire a 24% stake in Jinsha Molybdenum for 1.731 billion yuan [8] Group 3 - Nami Technology expects a net profit of 128 million to 145 million yuan for 2025, an increase of 54.51% to 75.03% year-on-year [9] - China State Construction reported a new contract total of 4.5458 trillion yuan for 2025, a 1% increase year-on-year [12] - China Metallurgical Group's new contract amount for 2025 is expected to decrease by 10.8% to 1.1136 trillion yuan [13] Group 4 - Beiding Co. reported a net profit of 111 million yuan for 2025, a year-on-year increase of 59.05% [14] - Southwest Securities expects a net profit of 1.028 billion to 1.098 billion yuan for 2025, an increase of 47% to 57% [15] - China Eastern Airlines reported a 4.93% year-on-year increase in passenger capacity for December 2025 [20] Group 5 - *ST Aowei's stock may be delisted due to a closing price below par value [21] - Yilian Network expects a net profit of 2.542 billion to 2.648 billion yuan for 2025, a decrease of 0% to 4% year-on-year [22] - Huochen Co. anticipates a net profit of 420 million to 540 million yuan for 2025, recovering from a loss of 2 million yuan in the previous year [17] Group 6 - Guoli Electronics expects a net profit of 68 million to 80 million yuan for 2025, an increase of 124.89% to 164.57% [28] - Jinchuan Group forecasts a net profit of 11 billion to 12 billion yuan for 2025, a year-on-year increase of 73.57% to 89.34% [41] - Triangle Tire plans to invest 3.219 billion yuan in a new tire project in Cambodia [42]

（文章来源：证券日报） 证券日报网讯 1月15日，力生制药发布公告称，公司第八届董事会第三次会议审议通过《关于2025年前 三季度利润分配的预案》等多项议案。 ...

格隆汇1月15日丨力生制药(002393.SZ)公布，根据公司的实际情况和股利分配政策，公司拟向全体股东 （公司回购专用证券账户除外）每10股派发现金红利人民币3.00元（含税），不送红股，不以资本公积 金转增股本。截至2026年1月15日，公司总股本257,616,859股，扣除回购专用账户699,980股和正在办理 注销手续的股权激励限售股30,016股，即以256,886,863股为基数计算2025年前三季度拟派发现金红利人 民币77,066,058.90元（含税）。 ...

Group 1 - The company, Lisheng Pharmaceutical (002393.SZ), announced a cash dividend distribution of RMB 3.00 per 10 shares (including tax) to all shareholders, excluding the repurchase special securities account [1] - As of January 15, 2026, the total share capital of the company is 257,616,859 shares, with 699,980 shares in the repurchase special account and 30,016 shares undergoing cancellation due to equity incentive restrictions, resulting in a base of 256,886,863 shares for the dividend calculation [1] - The total cash dividend to be distributed for the first three quarters of 2025 is RMB 77,066,058.90 (including tax) [1]

天津力生制药股份有限公司内幕信息知情人登记管理办法 天津力生制药股份有限公司 内幕信息知情人登记管理办法 （2026 年 1 月修订） 第一章 总 则 第一条 为规范天津力生制药股份有限公司(以下简称"公司")的内幕信息管理，加强内幕 信息保密工作，维护信息披露公平原则，根据《中华人民共和国公司法》（以下简称"公司 法"）、《中华人民共和国证券法》（以下简称"证券法"）、《上市公司信息披露管理办法》 《深圳证券交易所股票上市规则》《深圳证券交易所上市公司规范运作指引》《上市公司 监管指引第5号—上市公司内幕信息知情人登记管理制度》等相关法律法规、规范性文件及 《公司章程》的有关规定，制定本办法。 的参股公司。上述主体按照本办法及信息披露管理办法等要求，履行内部报告义务，建立 报告程序，明确负责人员的信息披露职责。 第二条 董事会是公司内幕信息的管理机构。公司董事长为内幕信息管理工作主要责任 人；公司董事会秘书为内幕信息管理工作负责人，负责办理上市公司内幕信息知情人的登 记入档事宜；证券事务部是公司信息披露管理、投资者关系管理、内幕信息登记备案的日 常办事机构，并负责公司内幕信息的监管工作。 第三条 董事会秘书 ...